Research report: Phenotypic Considerations for Tafamidis Use in a Real-World Cohort of Older Patients with Transthyretin Amyloid Cardiomyopathy
A pooled real-world analysis of 1,924 patients with transthyretin amyloid cardiomyopathy treated with tafamidis found that outcomes in patients aged ...
